Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reversible carbon-boron bond formation at platinum centers through σ-BH complexes. | Chem Sci | 2020 | 34163924 | PubTator, text mining | PubMed |
| Catalyst control of selectivity in the C-O bond alumination of biomass derived furans. | Chem Sci | 2020 | 34094157 | PubTator, text mining | PubMed |
| Palladium-catalysed C-F alumination of fluorobenzenes: mechanistic diversity and origin of selectivity. | Chem Sci | 2020 | 34094156 | PubTator, text mining | PubMed |
| Proceedings of the CIMAGO Meeting - Challenges in Oncobiology Coimbra, 31st january 2020. | Medicine (Baltimore) | 2020 | 33686047 | PubTator, text mining | PubMed |
| Aziridinium Ylides: Underutilized Intermediates for Complex Amine Synthesis. | Trends Chem | 2020 | 33665590 | PubTator, text mining | PubMed |
| Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy. | Front Oncol | 2020 | 33643907 | PubTator, text mining | PubMed |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. | J Oncol | 2020 | 33643409 | PubTator, text mining | PubMed |
| How selecting best upfront therapy for metastatic disease?-Focus on ROS1-rearranged disease. | Transl Lung Cancer Res | 2020 | 33489827 | PubTator, text mining | PubMed |
| Genomic alterations in thymoma-molecular pathogenesis? | J Thorac Dis | 2020 | 33447444 | PubTator, text mining | PubMed |
| Analysis of copy number variation in dogs implicates genomic structural variation in the development of anterior cruciate ligament rupture. | PLoS One | 2020 | 33382735 | PubTator, text mining | PubMed |
| A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer. | Int J Genomics | 2020 | 33381538 | PubTator, text mining | PubMed |
| In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia. | PLoS One | 2020 | 33370388 | PubTator, text mining | PubMed |
| Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. | Onco Targets Ther | 2020 | 33363385 | PubTator, text mining | PubMed |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. | Front Oncol | 2020 | 33363036 | PubTator, text mining | PubMed |
| Retinal organoids: a window into human retinal development. | Development | 2020 | 33361444 | PubTator, text mining | PubMed |
| Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma. | Cancers (Basel) | 2020 | 33352931 | PubTator, text mining | PubMed |
| Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI). | Diagn Pathol | 2020 | 33317587 | PubTator, text mining | PubMed |
| Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease. | Front Immunol | 2020 | 33281808 | PubTator, text mining | PubMed |
| Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy. | Oxf Med Case Reports | 2020 | 33269082 | PubTator, text mining | PubMed |
| Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction. | Nat Commun | 2020 | 33257699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=38